Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate. Despite their crucial role in neurobiology, the architecture and atomic structure of an intact ionotropic glutamate receptor are unknown. Here we report the crystal structure of the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 Å resolution in complex with a competitive antagonist. The receptor harbours an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry. A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D. Therefore, the stereochemical manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits. Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-D-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern. We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.
Ionotropic glutamate receptors mediate most excitatory neurotransmission in the central nervous system and function by opening a transmembrane ion channel upon binding of glutamate. Despite their crucial role in neurobiology, the architecture and atomic structure of an intact ionotropic glutamate receptor are unknown. Here we report the crystal structure of the a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-sensitive, homotetrameric, rat GluA2 receptor at 3.6 Å resolution in complex with a competitive antagonist. The receptor harbours an overall axis of two-fold symmetry with the extracellular domains organized as pairs of local dimers and with the ion channel domain exhibiting four-fold symmetry. A symmetry mismatch between the extracellular and ion channel domains is mediated by two pairs of conformationally distinct subunits, A/C and B/D. Therefore, the stereochemical manner in which the A/C subunits are coupled to the ion channel gate is different from the B/D subunits. Guided by the GluA2 structure and site-directed cysteine mutagenesis, we suggest that GluN1 and GluN2A NMDA (N-methyl-D-aspartate) receptors have a similar architecture, with subunits arranged in a 1-2-1-2 pattern. We exploit the GluA2 structure to develop mechanisms of ion channel activation, desensitization and inhibition by non-competitive antagonists and pore blockers.
The development and function of the human brain, and its remarkable capacity for experience-dependent change, hinges on the organization and dynamics of chemical synapses-communication 'contact zones' between neurons. At these specialized sites, chemical transmitters released from presynaptic terminals diffuse across the synaptic cleft and activate receptors localized primarily on the postsynaptic cell 1 , thereby transmitting the flow of information from one neuron to another. Glutamate is the predominant chemical transmitter of excitatory synapses in the central nervous system 2, 3 and receptors for this ubiquitous neurotransmitter are of two classes: metabotropic and ionotropic 4 . Ionotropic glutamate receptors (iGluRs) are ligand-gated ion channels fundamental to neurotransmission at excitatory synapses and are implicated in nearly all aspects of nervous system development and function 5 . iGluRs are also involved in chronic neurodegenerative conditions, in psychiatric disorders and in acute injury or trauma [6] [7] [8] [9] .
Comprising the iGluR receptor family are AMPA (GluA1-GluA4), kainate (GluK1-GluK5) and NMDA (GluN1, GluN2A-GluN2D, GluN3A-GluN3B) receptors [10] [11] [12] [13] [14] . Whereas NMDA receptors are obligate heterotetramers 14 , AMPA and kainate subunits form functional homotetramers [10] [11] [12] 15 , although native receptors are almost exclusively heterotetramers [16] [17] [18] . Each subunit has a modular composition 19 and includes a large extracellular amino-terminal domain (ATD) 20 that participates in subtype-specific receptor assembly, trafficking and modulation; a ligand-binding domain (LBD) central to agonist/competitive antagonist binding and to activation gating 21 ; a transmembrane domain (TMD) that forms the membrane-spanning ion channel 22 ; and a cytoplasmic carboxy-terminal domain involved in receptor localization and regulation 23 . AMPA, kainate and NMDA receptors are related in amino acid sequence yet they are divergent with respect to function 5, 24 . Whereas non-NMDA receptors exhibit kinetics of activation, deactivation and desensitization on a millisecond timescale 25 , NMDA receptors are slower, with corresponding molecular processes occurring on a timescale of tens to hundreds of milliseconds 26 . Furthermore, AMPA and kainate receptors only demand glutamate for activation, whereas NMDA receptors function as coincidence detectors, requiring membrane depolarization to relieve magnesium block 27 together with binding of glycine 28 and glutamate. AMPA receptors sojourn through multiple sub-conductance states contingent upon agonist concentration 15, 29 , indicating independent LBDs and a sequential mechanism of activation 30 . AMPA and kainate receptors undergo profound desensitization, whereas NMDA receptors desensitize less profoundly and by way of glycine-dependent and glycine-independent mechanisms 31 . The pharmacology of iGluR family members is distinct. AMPA receptors, for example, are non-competitively antagonized by small molecules binding to the juxta-membrane region 32 . By contrast, the ATDs of NMDA receptors harbour binding sites for polyamines, protons, zinc ions and ifenprodil 26, 33 . In AMPA receptors, the LBD possesses binding sites for modulators of receptor desensitization and deactivation 34, 35 . All iGluR subtypes, however, possess binding sites for pore blockers within the transmembrane ion channel 36 . Despite divergent functional properties, iGluR family members have a common structural design. Clues to the symmetry and architecture of iGluRs derive from studies of isolated domains, demonstrating that ATDs and LBDs assemble as dimeric entities 34, [37] [38] [39] [40] ; from electron microscopy on intact receptors, showing an overall two-fold symmetry 41, 42 ; and from amino acid sequence analysis and biophysical studies, indicating a ,4-fold symmetric ion channel 19, 43 . Absent from our understanding, however, is an accurate, atomic-resolution description of iGluR architecture and symmetry, a definition of subunit arrangement in homomeric AMPA and heteromeric NMDA receptors 44, 45 , and proof of the symmetry mismatch between the two-fold symmetric extracellular domains and the presumably four-fold symmetric ion channel 34 . To answer these fundamental questions, we embarked on crystallographic and functional studies of a full-length eukaryotic iGluR.
Crystallization and structure determination We exploited fluorescence-detection size-exclusion chromatography (FSEC) 46 to discover that the rat GluA2 receptor 10, 11 , expressed as the unedited 47 , 'flip' variant 48 , was a promising candidate for structural studies ( Supplementary Fig. 3a) . We further harnessed FSEC to find that n-undecyl-b-D-thiomaltoside, the competitive antagonist ZK200775 (ref. 49 ) and a modified receptor polypeptide, termed GluA2 cryst , were the optimal detergent, ligand and protein construct for crystallization trials, respectively (Supplementary Figs 1, 2 , 3b-d and 4-6). GluA2 cryst binds 3 H-AMPA with a dissociation constant (K d ) of 3.5 6 0.5 nM and yields glutamate-gated currents similar to the wild-type receptor ( Supplementary Figs 7 and 8) . Crystals of GluA2 cryst belong to the P1 space group, contain one tetrameric receptor in the unit cell and diffract to 3.6 Å resolution (Supplementary Fig. 9 and Supplementary Table 1) .
We solved the GluA2 cryst structure by molecular replacement, using the high-resolution structures of the isolated GluA2 ATD 39 and the antagonist-bound form of the isolated GluA2 LBD 38 as search probes. Phases were improved by multidomain non-crystallographic symmetry (NCS) averaging, solvent flattening and histogram matching. The resulting electron density maps were of sufficient clarity to build the transmembrane helices comprising the ion channel domain and the linking polypeptides connecting the LBD to the ion channel and the ATD to the LBD (Supplementary Figs 10-12 ). The weakest density was observed for the S2-M4 linker connecting the LBD and the M4 transmembrane domain. Residues on the cytoplasmic side of the membrane connecting membrane helices M1 to M2, and M2 to M3, were not visible in electron density maps.
We probed the veracity of the polypeptide trace by preparing selenomethionine (SeMet)-labelled receptor of GluA2 cryst and of four methionine point mutants at Leu 542 (M1), Gln 586 (Q/R site, M2) 47 , Ile 612 (M3) and Val 800 (M4) and by inspecting the corresponding anomalous difference Fourier maps. We formed crystals with a mercury-labelled variant of ZK200775, measured diffraction data at the Hg L III peak, mapped the antagonist binding site in the LBDs, and found additional mercury binding sites, presumably due to residual methyl mercury chloride (Supplementary Table 1 receptor. a, View of the 'broad' face of the receptor, perpendicular to the overall two-fold axis of molecular symmetry. Each subunit is in a different colour. b, View of the 'narrow' face of the receptor. In a and b competitive antagonist molecules lodged within each LBD clamshell are shown in space-filling representation. c, d, Axes of symmetry viewed parallel to the membrane (c) or from the extracellular 'top' of the receptor, along the overall two-fold axis of symmetry (d). Axes of local symmetry for the domains ATD, LBD and TMD are shown in purple, orange and green, respectively. For ATD and LBD, thin lines represent axes of intradimer two-fold symmetry and thick lines represent axes of interdimer twofold symmetry. For TMD, the thick green line represents the local axis of four-fold symmetry. Red mesh peaks (c, d) define mercury sites derived from an anomalous difference Fourier map of a GluA2 cryst mercury derivative. The contour level is 5.0s. experimental structure, which was refined to good crystallographic statistics and stereochemistry (Supplementary Table 2 ).
Architecture and symmetry
The GluA2 receptor has a shape like the capital letter 'Y' where the three major domains are arranged in layers (Fig. 1a, b) . The TMDs form the ion channel and define the narrow 'base', the ATDs are splayed outward, like diverging prongs, at the 'top' of the Y, and the LBDs, in complex with antagonist molecules, are sandwiched in between the ion channel and ATDs. In this closed, antagonist-bound state of the receptor there are no prominent vestibules or cavities near the ion channel domain and instead the LBD layer rests like a thick slab on top of the ion channel pore (Supplementary Fig. 17 ).
The symmetry and subunit arrangement of the tetrameric GluA2 receptor is without precedent. The receptor has an overall yet approximate two-fold axis of molecular symmetry oriented perpendicular to the membrane plane (Fig. 1c, d and Supplementary Fig. 16 ). This two-fold axis of symmetry relates one ATD dimer 39 to another, one LBD dimer 34 to the second, and half of the pore-forming TMDs to the other half. The ion channel domain has an approximate four-fold axis of rotational symmetry (Fig. 1c, d ).
Each prong of the receptor Y is defined by an ATD dimer in which the 'local' dimer two-fold axis is oriented ,24u off of the overall twofold axis (Fig. 1c, d ). 'Below' the ATDs are the LBDs, also organized as a pair of dimers in which the local two-fold axes within each dimer are also tipped off the overall two-fold axis of symmetry by ,19u and are thus not aligned with the 'local' ATD two-folds. 'Below' the LBDs the four-fold axis of the ion channel is approximately aligned with the overall two-fold axis of symmetry. The multiple, non-aligned axes of local symmetry, together with the two-fold symmetry of the LBDs and the four-fold symmetry of the ion channel, result in symmetry mismatches between the ATDs, LBDs and TMDs.
Extracellular domains
The ATD, implicated in receptor assembly, trafficking and localization, forms two distinct types of subunit-subunit contacts (Fig. 2) . On the one hand, within each ATD 'dimer', there are extensive subunit-subunit contacts (A-B or C-D) that are indistinguishable from the contacts seen in the high-resolution crystal structures of the isolated GluA2 ATDs 39 ( Supplementary Fig. 18a ). On the other hand there is an interface between ATD dimers (,330 Å 2 ), located on the overall axis of two-fold symmetry, that is mediated by residues on the L2 lobes of the B and D subunits (Fig. 2b) . Within the context of the ATD 'layer', we define the B/D and A/C subunits as 'proximal' and 'distal' to the overall two-fold axis of symmetry. The B-D dimer-dimer interface, although small, is observed in the packing of GluA2 ATD dimers in crystals of the isolated ATD 39 ( Supplementary Fig. 18b ). We suggest that the ATD B-D interface, together with the subunit 'crossover' between the ATD and LBD layers, provides a molecular explanation for the role that the ATD has in the assembly and stability of the tetrameric receptor.
At the LBD layer each agonist binding domain is also a partner in readily identifiable 'dimers' and these dimers, in turn, interact across the overall two-fold axis (Fig. 2c) . As a consequence of the subunit crossover between the ATD and LBD layers, the local LBD dimers are formed by the A-D and B-C subunits, with the A and C subunits and the B and D subunits proximal and distal to the overall two-fold axis, respectively. Within a LBD dimer there are multiple contacts between domain 1 of each subunit, recapitulating the interactions seen in the high-resolution crystal structures of the isolated, water-soluble GluA2 LBD 38 . In the Subunits B and D are proximal and subunits A and C are distal to the overall two-fold axis, respectively. c, The LBD layer with the dimer-dimer contacts on and off the overall two-fold axis shown in panels 2 and 3, respectively. In this layer, subunits A and C are proximal to the overall two-fold axis. d, The TMD layer and its four-fold rotational symmetry (black square). GluA2 cryst structure, which corresponds to an antagonist-bound, nondesensitized state, the domain 1-domain 1 interface is 'intact', as visualized in the wild type 38 , the Leu 483 to Tyr mutant or the cyclothiazide 34 and aniracetam-bound 35 structures of the isolated LBD. Domain 2, by contrast, does not participate in significant intersubunit interactions within a LBD dimer, a finding that is also in harmony with high-resolution studies of the isolated LBD 50 . Lodged in the 'clamshell' of each LBD is a bound antagonist, thus proving that the agonist/competitive antagonist binding site is located within and not between subunits.
There is a small (,224 Å 2 ) interface between LBD dimers, an area consistent with weak dimer-dimer interactions 34, 51 . Like the ATD dimer-dimer interface, the LBD dimer interface is located on the overall two-fold axis of symmetry and is composed primarily of residues at the 'bend' between helices F and G, with the a-carbon atoms of residues Lys 663, Ile 664 and Ala 665 of subunits A and C 8-13 Å apart. The relationship between LBD dimers is not perfectly two-fold symmetric, however, and whereas residues at the end of helices G and K of the A and B subunits (Ser 676 and Lys 770) are in van der Waals contact (Ca-Ca distance of 6.1 Å ), the equivalent residues in subunits C and D are not in contact (Ca-Ca distance of 9.7 Å ).
Transmembrane domain
Viewed from the extracellular side of the membrane down the overall two-fold axis of symmetry, four GluA2 cryst subunits arrange their transmembrane domains around an axis of ,4-fold rotational symmetry (Fig. 2d ). In accord with topology studies 52, 53 , each subunit has three transmembrane helices (M1, M3 and M4), a central pore-like helix (M2) 54 and a polypeptide pore-lining loop that is disordered in our electron density maps (Fig. 3a, b) . Leading from the LBD, the S1-M1 polypeptide segment adopts an extended conformation until reaching the TMD, at which point the polypeptide forms a ,90u turn and initiates a short helix (pre-M1) oriented nearly parallel to the membrane. The pre-M1 helix acts like a cuff around the 'top' of the ion channel domain, making contacts with carboxyl and aminoterminal ends of helices M3 and M4, respectively. M1 is the first bona fide transmembrane segment and it resides on the exterior of the ion channel domain (Fig. 3c) . Within the pore lies the M2 helix, positioned largely on the basis of tube-shaped electron density and the anomalous difference density peak from the SeMet-labelled Gln 586 to Met (Q/R site) mutant. The M3 helices line the inside of the ion channel domain, are ,52 Å in length and, in the present, antagonist bound structure, cross at the level of the pre-M1 cuff helices, near the membrane-aqueous solution boundary, forming a ,12 Å occlusion of the putative ion permeation pathway. Residing on the exterior of the ion channel domain is the M4 helix, connected to the S2 segment of the LBD by two turns of helix and a short extended region of polypeptide. There are extensive subunit-subunit interactions between the transmembrane segments with the M4 segment of one subunit making interactions primarily with the transmembrane domains of an adjacent subunit (Fig. 3d) . These interactions provide a molecular basis for the crucial role of the M4 helix in receptor assembly and function 22 .
Probing subunit interfaces
Cognisant that the GluA2 cryst structure (Fig. 4a ) possesses an unorthodox subunit arrangement and molecular symmetry, we tested whether the subunit arrangement and domain-domain contacts in the crystal structure reflect interactions adopted by the receptor in a noncrystalline environment. To accomplish this, we introduced cysteine residues into the three unexplored interfaces at sites that should result in spontaneous disulphide bond formation ( Fig. 4b-d) . We purified the mutant, tetrameric receptors to homogeneity and probed the extent of spontaneous subunit crosslinking by gel electrophoresis under reducing and non-reducing conditions (Fig. 4e-g and Supplementary Fig. 19 ).
At the ATD, dimer-dimer, B to D subunit interface, we introduced a cysteine at Val 209 (Fig. 4b ). For the wild-type-like receptor, in the presence or absence of reducing agent, the GluA2 subunit migrates at a position consistent with its calculated molecular mass. By contrast, for the Val 209 to Cys mutant, we observe reducing-agent-dependent dimer formation, thus supporting the presence of this dimer-dimer interface in the intact receptor under native conditions (Fig. 4e) . In the LBD layer, there are two distinct subunit-subunit interfaces. One interface is within a LBD dimer and is formed by extensive contacts between domain 1 of two-fold related subunits, faithfully mirroring the thoroughly documented dimer interface observed in the isolated LBDs of AMPA 34, 38, 51 , kainate 55 and NMDA 56, 57 receptors. The second interface, between subunits (A and C) proximal to the overall two-fold axis, is composed of only a handful of intersubunit contacts (Fig. 4c) . We therefore tested whether residues in this interface could form inter-dimer disulphide crosslinks. At both Lys 663 and Ile 664 cysteine mutants formed redox-dependent dimers (Fig. 4f) , supporting the presence of this interface in the intact receptor. This LBD dimerdimer interface is also important for agonist-dependent gating because steady-state currents of the Ile 664 to Cys mutant are potentiated ,5-fold after receptor reduction 58 ( Supplementary Fig. 20 ). The apex of the ion channel domain, defined by the C-terminal ends of M3, provides an important test of the GluA2 cryst structure, not only because residues at the end of M3 define the gate of the ion channel in this antagonist-bound state, but also because the end of M3 and the M3-S2 linker span the transition between the four-fold symmetry of the ion channel and the two-fold symmetry of the extracellular domains. In two subunits (A and C), the Met 629 side chains point towards each other and the a-carbons are separated by ,12 Å , whereas the corresponding a-carbon atoms in subunits B and D are 30 Å apart (Fig. 4d) . In satisfying agreement with the GluA2 cryst structure, we find that cysteines introduced at position 629 form redox-dependent crosslinks (Fig. 4g) , consistent with the proximity of Met 629 residues and the structure of the ion channel domain. We may not see complete crosslinking to a dimer position because of the overall two-fold symmetry of the extracellular domains or because some of the cysteine residues may have suffered chemical modification during expression or purification.
We propose that the architecture of kainate receptors is similar to that of the GluA2 cryst AMPA receptor based on the remarkable observation that the isolated GluK2 ATD dimer forms a similar dimer-of-dimers arrangement in the crystal lattice, yielding a 'tetrameric' complex 40 like that in the GluA2 cryst structure (Supplementary Fig. 21 ). Superposition of a-carbon atoms for 292 residues per subunit in the structurally conserved regions of GluA2 cryst and isolated GluK2 ATD dimer-of-dimers yields a root mean square deviation (r.m.s.d.) of 3.2 Å . This observation, in combination with the fact that LBDs of AMPA and kainate receptors form similar local dimers 55 , demonstrates that principles of architecture and symmetry are conserved between AMPA and kainate receptors.
Architecture of NMDA receptors NMDA receptors are the most complex subfamily of ionotropic glutamate receptors, not only because they are obligate heterotetramers, requiring a glycine-binding GluN1 or GluN3 subunit together with a glutamate binding GluN2 subunit, but also because their ATDs bind ions and molecules that modulate receptor activity 26 . Even though the structure of the GluN1-GluN2A LBD heterodimer is known 56 , there is no conclusive experimental knowledge of how subunits are arranged in heterotetrameric NMDA receptors. To determine whether the GluA2 cryst structure provides a paradigm for understanding NMDA receptor architecture, we carried out cysteine-directed crosslinking experiments on the rat GluN1-GluN2A NMDA receptor.
Guided by superpositions of the GluN1-GluN2A LBD heterodimer 56 onto the GluA2 cryst structure, we designed cysteine substitutions at putative interdimer interfaces. There are three possible arrangements of the GluN1-GluN2A LBD heterodimers within a heterotetrameric receptor and we can distinguish between these models depending on whether redox-dependent crosslinking requires cysteine substitutions in only GluN1, in only GluN2A or in both GluN1 and GluN2A subunits (Supplementary Figs 22 and  23) . Remarkably, only a single cysteine substitution in GluN1, at Glu 699, is required to crosslink NMDA receptor subunits at the LBD level (Fig. 5a) . Indeed, none of the six cysteine substitutions in GluN2A promoted crosslinking, whereas simultaneous substitutions in both GluN1 and GluN2A resulted in crosslinking similar to substitutions in GluN1 alone. Within the LBD layer of the NMDA receptor, therefore, we propose that GluN1 and GluN2A subunits form diagonal pairs with the GluN1 subunit proximal to the overall two-fold axis of symmetry (Fig. 5b) .
What is the arrangement of NMDA receptors within their TMD? Here we exploit the GluN1 and GluN2A equivalents of GluA2 residue Met 629. Because the GluN1 subunit is proximal to the overall twofold axis of symmetry at the LBD layer, we predict that the GluN1 ARTICLES residue, Pro 661, will be proximal to the overall two-fold axis at the TMD layer and that the GluN2A residue, Phe 631, will be too far away to form a crosslink (Fig. 5c ). In concordance with this prediction, GluN1(Pro661Cys)-GluN2A(wild type) but not GluN1(wild type)-GluN2A(Phe631Cys) receptors demonstrate redox-dependent crosslinking (Fig. 5a ). Even though we have not explored crosslinking of NMDA receptors' ATDs, based on our observation that subunits switch proximity to the overall two-fold axis between the ATD and LBD layers, we predict that the ATDs are assembled as 'local' heterodimers and that NR2 ATDs mediate the dimer-dimer contacts, proximal to an overall two-fold axis of symmetry (Fig. 5d) . This arrangement would appropriately position the L2 lobe of the GluN2A ATD to alter receptor structure and function by either modulating ATD dimer-dimer contacts or ATD-LBD interactions, ultimately influencing ion-channel gating via perturbation of the LBD 26, 57 .
Subunit non-equivalence and domain swapping
There is a remarkable swapping of domains, involved in local dimers between subunits, that is illustrated by tracing neighbouring polypeptide chains through the receptor. Within the ATD layer, subunits A and B interact with each other to form a local ATD dimer (red dimer, Fig. 6a, d ). When the polypeptide chains of subunits A and B pass to the LBD layer, however, subunit A forms a LBD dimer with the corresponding domain of subunit D (blue dimer, Fig. 6a ), while subunit B associates with subunit C (orange dimer, Fig. 6d ). Within the TMD, the transmembrane helices of subunits A and B form extensive contacts with each other as well as with subunits C and D (Fig. 3c, d) .
The swapping of extensive local dimer interactions between subunits and the symmetry mismatch between the LBDs and TMDs mean that within this homotetrameric receptor, where each subunit is chemically identical, there are two conformationally different subunit pairs related by the overall axis of two-fold molecular symmetry: subunit A is equivalent to C and subunit B is equivalent to D yet the A/C pair is distinct, in conformation, from the B/D couple (Fig. 6c, f) . These differences in conformation can be illustrated by superimposing the LBDs of subunits A and B (Fig. 6b, e) , showing the large differences in orientation of the flanking ATDs and TMDs. In subunit A or C, for example, there is a substantial interface between the ATD and LBD (,315 Å 2 ), whereas in subunit B or D there are no similar contacts (Fig. 6b, e) . Another fundamental difference is that the LBD of the B/D subunits is ,6 Å closer to the putative membrane plane than the A/C subunit pair.
The conformational difference between the two types of subunits is defined by polypeptides linking the ATDs, LBDs and TMDs that have the same amino acid sequence but adopt different conformations. These polypeptides also mediate symmetry transitions between domain layers. The symmetry mismatch between the ATDs and the LBDs, characterized by different orientations of their local two-fold axes of symmetry (Fig. 1c, d ) and domain swapping (Fig. 6a, d) , is mediated by the ATD-S1 linkers (Thr 377-Lys 393). On the one hand, the ATDs of the A and C subunits interact with their LBDs via an ATD-LBD interface (Fig. 6a-c) and the ATD-S1 linkers adopt a more compact conformation. On the other hand, the ATDs of the B and D subunits are suspended between LBD dimers and the ATD-S1 linker nearly spans a LBD dimer, taking on an extended conformation (Fig. 6d-f) .
Two-fold to four-fold symmetry transition
On the extracellular side of the membrane, both the ATD dimers and the LBD dimers are arranged with an overall two-fold symmetry. By contrast, the GluA2 cryst TMD has four-fold rotational symmetry (Fig. 3c) . Where is the two-fold to four-fold symmetry mismatch structurally reconciled? We can answer this question by examining selenium and mercury positions derived from SeMet-labelled receptor and from crystals grown with the mercury-containing antagonist. Selenium sites at Met 629, a residue within the highly conserved 'Glu-Arg-Met-Val' sequence at the end of M3 immediately preceding the S2 segment, clearly show two-fold symmetry (Fig. 7a, b) . Mercury sites at Cys 528, near the extracellular end of M1, however, demonstrate unambiguous four-fold symmetry (Fig. 7a, b) . By viewing the receptor perpendicular to the overall two-fold axis, and defining the approximate membrane boundary based on residue polarity, we see that Met 629 is just 'outside' of the membrane-spanning region whereas Cys 528 resides within the membrane bilayer. The two-fold to four-fold symmetry transition occurs within this region, a ,10-Å thick slab between the LBDs and TMDs (Fig. 7c) .
To define precisely where the transition occurs, we applied the four-fold rotational transformation associated with the TMDs to one of the receptor subunits and calculated the r.m.s.d. of a-carbon atom positions between the superimposed subunits. Where the receptor conforms to four-fold symmetry, the r.m.s.d. values in atom positions are on the order of the coordinate uncertainty. In two-fold symmetric regions, however, the r.m.s.d. values in atom positions are much greater. Thus, by plotting the r.m.s.d. in atom positions as a function of distance along the overall two-fold axis, we can follow the two-fold to four-fold symmetry transition (Fig. 7d) . This analysis demonstrates that the transition is abrupt and is located at the boundary of the extracellular leaflet of the membrane bilayer, adjacent to the region of the ion channel domain encircled by the pre-M1 cuff helical segments.
Gating machinery and symmetry mismatch
The symmetry mismatch between the LBDs and the TMDs is resolved by three linking peptides-the S1-M1 (Lys 506-Gly 513), M3-S2 (Val 626-Glu 634) and S2-M4 (Gly 774-Ser 788) linkers-making the transition from the two-fold, parallelogram-like symmetry of the LBDs to the four-fold symmetric, square geometry of the TMDs (Fig. 8a) . Indeed, these are the central elements of the iGluR gating machinery that transform ligand-induced structural changes in the LBD dimers into the movement of the transmembrane domains that opens and closes the central pore of the four-fold symmetric ion channel. In bridging two-fold to four-fold symmetry transition, the peptide segments linking the LBDs and TMDs can be grouped into two pairs that belong to diagonal subunits A/C or B/D; within each group, the linkers adopt approximately similar conformations whereas between the groups the conformations are clearly distinct. Accommodation of the two-fold to four-fold symmetry mismatch is illustrated by the different conformations of the S1-M1 linkers which, when passing from the b7 strand of the LBD to M1 (TMD), either come from inside (A/C) or outside (B/D) of the 'M1 circle' (Fig. 8b) . The M3-S2 linker provides a particularly striking example of how the conformations of the A/C and B/D linking peptides differ. In the A and C subunits, the M3-S2 linker adopts a helical conformation to Met 629 (Fig. 4d) . For the B and D subunits, by contrast, the helical conformation is broken at Val 626 and following this residue, the peptide adopts an extended conformation. The difference in mainchain conformation means that the a-carbon atoms of Pro 632 in the A and C subunits are ,27 Å apart whereas the corresponding atoms in the B and D subunits are separated by ,50 Å (Fig. 8c) . A third striking illustration is provided by Cys 773, a conserved residue at the end of helix K of the LBD. For Cys 773, in subunits B and D, the a-carbons are 33 Å apart and in the A and C subunits, the span is much larger, 69 Å . To reach the M4 in TMD, which possesses four-fold symmetry and where the distances between the same atom in the A/C and B/D subunits are necessarily the same, the A/C and B/D S2-M4 linkers take on different conformations and different orientations relative to the overall two-fold axis (Fig. 8d) .
The ion channel
The four-fold rotationally symmetric GluA2 cryst ion channel is shaped like a Mayan temple with a broad cytoplasmic base, ,42 Å on a side, and with a bluntly pointed extracellular 'top'. In the present, competitive antagonist-bound state, the ion channel unambiguously adopts a closed conformation by the crossing of the M3 helices (Fig. 9) . The crossing of the helices occurs near the highly conserved Ser-Tyr-Thr-Ala-Asn-LeuAla-Ala-Phe (SYTANLAAF) motif, with Thr 617, Ala 621 and Thr 625 occluding the ion channel permeation pathway 22, 59 . In the Lurcher mouse 60 there is a substitution of Ala 636 by Thr in the GluD2 subunit, leading to spontaneously opening ion channels 61 . The equivalent residue in GluA2 (Ala 622) participates in close contacts with the M3 helix of a neighbouring subunit, indicating that introduction of bulky residues can directly destabilize the tight helix crossing associated with the resting, closed state of the receptor, leading to constitutively open ion channels. The ion channel permeation pathway is also occluded above the SYTANLAAF motif by a pair of Met 629 residues on the A/C subunits protruding their side chains towards the centre of the pore. Notably, these methionines are adjacent to the Glu 627-Arg 628 motif that, when mutated, strongly perturbs receptor desensitization 62 . Stimulated by hypotheses 19 and experimental data 43, 63 proposing a common architecture for the ion channel pores of iGluRs and K 1 channels, we superimposed the transmembrane domains of GluA2 cryst onto the bacterial K 1 channel KcsA 54 ( Fig. 10 and Supplementary  Fig. 24 ). Despite the low pairwise identity of ,20% between the aligned amino acid sequences of the rat GluA2 receptor channel and KcsA ( Supplementary Fig. 25 ), the M1, M2 and M3 segments of GluA2 cryst overlap remarkably well with structurally equivalent portions of KcsA (Fig. 10a) . In fact, superposition of a-carbon atoms for 64 residues per subunit in GluA2 cryst and KcsA yields a r.m.s.d. of 2.2 Å . Not included in this comparison was transmembrane segment M4, which is absent in KcsA and bacterial glutamate receptors 64 . In addition to the overall similarity, the structural alignment demonstrates that the occlusion of the ion conductive pathway, that is, the regions of these channels involved in gating and defined by the carboxyl terminal region of M3 in GluA2 cryst and TM2 in KcsA, is remarkably similar (Fig. 10b) . By contrast, the region of KcsA that confers ion selectivity-the extended Thr-Val-Gly-Tyr-Gly selectivity filter-is completely different in amino acid sequence in iGluRs and is disordered in the GluA2 cryst structure, observations consistent with the fact that K 1 channels are highly selective and iGluRs are not.
The pre-M1 cuff helix is oriented nearly parallel to the membrane, at the interface between the membrane and extracellular solution, and is a structural feature that underscores similarities and differences between iGluRs and K 1 channels
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. Appearing as a 'collar' around the TMD bundle, the pre-M1 helices may restrain the mobility of M3 in the closed state and, by virtue of its connection via the S1-M1 linker to the LBD, promote opening of the ion channel gate upon agonist binding to the LBD. Whereas some K 1 channels have a similar element of structure 65 , the length of the helical segment as well as its conformation relative to the ion channel diverge from the GluA2 cryst pre-M1 helix. In fact, Pro 520 in the 'elbow' of the GluA2 cryst pre-M1 is highly conserved across iGluR subtypes yet is missing in K 1 channels ( Supplementary  Fig. 25 ), possibly indicating a distinct role of the pre-M1 element in iGluR structure and gating.
Immediately above the Q/R site, clearly within the transmembrane portion of the ion channel domain, is a central cavity (Fig. 9a ) similar to that observed in potassium channels 54 . In the GluA2 cryst structure there are conspicuous 'gaps' between the transmembrane domains that result in a portal between the central cavity, within the ion channel, and the membrane environment. We speculate that this portal may be occupied by residues projecting from the transmembrane domains of AMPA receptor auxiliary subunits 66, 67 , thus providing a mechanism by which auxiliary subunits modulate ion channel properties, such as the extent of block by polyamines 68 . The amino acid sequence and structural relationships between GluA2 cryst and K 1 ion channel pores allow us to speculate on the conformation of an iGluR in an open channel state ( Supplementary  Figs 25 and 26) . On the basis of superimposing the ion channels of GluA2 cryst and Shaker 65 , we suggest that the transmembrane helices of iGluR will bend and splay away from the central axis of the channel, mimicking the iris-like opening of K 1 channels. Although roughly similar in overall nature, the TMD movements during activation gating of iGluRs and K 1 channels may be different in molecular detail 69 . In fact, the residues lining the ion permeation pathway or the amino acids that perturb gating via genetic or chemical modification, together with the types of non-competitive antagonists and channel blockers that bind to the TMD, both in AMPA (Supplementary Fig. 27 ) and NMDA ( Supplementary Fig. 28 ) receptors, are highly specific to iGluRs, thus providing further evidence of distinction from potassium channels.
Mechanism of activation
The GluA2 cryst structure allows us to interpret decades of studies in the context of an intact receptor. Most fundamentally, the GluA2 cryst structure proves that agonist binding sites are located within individual subunit 'clamshells' and not between subunits, as is the case with trimeric P2X 70 and pentameric Cys-loop 71 receptors. This architectural principle is consistent with the observations that binding of multiple agonist molecules and subsequent ion channel activation are largely stepwise, sequential processes 15 . Indeed, the independence of LBD function is further supported by the fact that they can be genetically excised and studied as isolated soluble domains 72 . Together, these properties justify exploiting the wealth of structural and biophysical experiments on soluble LBDs of AMPA 38, 58, 73 , kainate 55, 74 and NMDA receptors 56, 75, 76 to illuminate principles of gating in full-length iGluRs. The GluA2 cryst structure is a complex with the high-affinity competitive antagonist ZK200775. Antagonist binding stabilizes the binding domain clamshell in an open conformation (Supplementary Fig. 29 ) 38 and, in the context of the LBD dimer, places the transmembrane-associated linker regions closest together (Supplementary Fig. 30 ). The conformation of the LBD trapped by ZK200775, although similar to the apo resting state reported for the isolated LBD 38 , is nevertheless more open or overextended (Supplementary Fig. 31 ). Binding of full agonists, such as glutamate, quisqualate or AMPA, results in closure of the clamshell by movement of domain 2 closer to domain 1 by a ,25u rotation (Supplementary Figs 30 and 31 ) 38, 77 . In the context of the water-soluble LBD dimer, closure of both clamshells increases the separation of the regions linking the binding domains to the transmembrane domains by ,20 Å , using the a-carbon of Pro 632 (M3-S2 linker) as a reference ( Supplementary Fig. 30 ). This movement, therefore, 'pulls apart' the M3 helices at the bundle crossing, opens the ion channel, and is the fundamental conformational change, within the binding domains, that transmits the energy associated with agonist binding to the work required to open the ion channel.
Superposition of two 'dimer' structures of the soluble LBD glutamate complex 38 onto the LBDs of the GluA2 cryst structure allows us to visualize activation-related movements in the context of the tetrameric receptor ( Fig. 11 and Supplementary Fig. 32 ). Using a-carbon atoms of residues Lys 506, Pro 632 and Cys 773 as reference points for the S1-M1, M3-S2 and S2-M4 linkers, respectively ( Supplementary  Fig. 33 ), the most significant movement involves the M3-S2 linker, an observation in agreement with the critical role of the M3 helix in channel gating. As a consequence of the overall two-fold symmetry relating one ligand binding domain dimer to the other, the movements of the M3-S2 linkers are ,2-fold symmetric, that is, there are large conformational changes within dimers and smaller changes between dimers (Fig. 11c, d ), consistent with chemical modification studies suggesting a breakdown in the four-fold symmetry of the ion channel upon receptor activation 78 . Augmenting the intradimer motions of this simple model, there is almost certainly a perpendicular component of movement, between LBD dimers, to facilitate opening of the ,4-fold symmetric pore. A component of movement between dimers is supported by the observation that reduction of the Ile 664 disulphide bridge potentiates glutamate-induced GluA2 currents 58, 79 ( Supplementary Fig. 20 ). The differences in position and conformations of the LBD-TMD linkers between the A/C (proximal) and B/D (distal) subunit pairs also mean that the consequences of agonist binding and LBD clamshell closure on the TMD must necessarily be distinct (Fig. 11c, d ). Evidence of this distinction can be seen by measuring the minimal distance between a reference residue within the M3-S2 linker, such as Pro 632, and the overall two-fold axis of symmetry, which is approximately coaxial with the four-fold axis of the TMD (Fig. 11c, d) . In so doing, we see that the a-carbon of Pro 632 is ,13 Å and 25 Å distal from the two-fold axis for the A/C and the B/D subunits, respectively. Upon agonist binding and LBD closure, we predict that the a-carbons of Pro 632 will move away from the two-fold axis by ,4 Å and 7 Å for the A/C and B/D subunits, respectively. Thus, the extent of conformational movement for the proximal (A/C) and distal (B/D) subunits is substantially different and is greater for the distal (B/D) subunits. We therefore hypothesize that not only will the consequence of agonist binding to ion-channel gating be different for the proximal (A/C) and distal (B/D) subunits, but that the agonist-induced conformational changes in the distal subunits may be more important to activation gating, simply because the extent of the predicted conformational change is larger. Conversely, we suggest that agonistinduced conformational changes in the proximal subunits may have a comparatively smaller role in activation gating. This explains, at least in part, why in NMDA receptors glycine binding to the GluN1 subunit, which we predict occupies the proximal position in the LBD layer and thus transmits a smaller conformational displacement to the TMD in comparison to the distal subunits, does not result in significant ion channel opening in the absence of glutamate.
Mechanism of desensitization
A hallmark of AMPA and kainate receptors is rapid and profound desensitization, or ion channel closure, after receptor activation 12, 48 . The molecular principles of desensitization and the structural relationships between the resting/closed and desensitized states of the ion channel pore are not yet understood for an intact receptor. To address these questions we can exploit the desensitized-like structure of the Ser 729 to Cys (S729C) mutant of the isolated LBD dimer 58 . By superimposing the desensitized-like S729C dimer onto the GluA2 cryst structure we find that both D2 lobes of the isolated dimer superimpose well on the corresponding lobes of the tetrameric receptor, even though the isolated domains are bound with glutamate (closed clamshell) and in GluA2 cryst , the LBDs are 'open' and bound with antagonist. This analysis demonstrates that peptide linkers connecting the LBDs to the TMDs can adopt a similar separation in the antagonist-bound GluA2 cryst state and in the glutamate-bound S729C desensitized-like dimer form ( Fig. 12 and Supplementary  Fig. 30 ). Desensitization therefore simply involves rupture of the LBD D1-D1 interface and rotation of entire binding domain subunits to allow for the D2 domains and the linkers to the ion channel to adopt a closed-state-like conformation.
In the context of the GluA2 cryst structure, rearrangement of D1-D1 LBD interface during desensitization (Fig. 12c) demands movement of the ATDs and the ATD-LBD linkers (Fig. 12b) . Upon receptor desensitization, we predict changes in both the distances between and within ATD dimers. These observations provide mechanisms, grounded in three-dimensional structure, by which binding of ions and small molecules to the ATDs of NMDA receptors can modulate receptor function 80 . Ligands alter the conformation of the ATD clamshell and propagate these conformational changes throughout the receptor either directly, through the ATD-LBD linkers, or indirectly, via changes in the ATD dimer-dimer contacts across the overall twofold axis of symmetry.
Conclusion
The GluA2 cryst structure uncovers domain organization and molecular symmetry of iGluRs. Crystallographic and site-directed chemical modification data demonstrate that AMPA, kainate and NMDA receptors have ,2-fold symmetric 'dimeric' extracellular domains, a ,4-fold symmetric ion channel, and a symmetry mismatch that renders diagonally related subunit pairs distinct. In heterotetrameric GluN1/ GluN2A NMDA receptors, subunits are positioned in a GluN1-GluN2A-GluN1-GluN2A pattern. Activation gating of iGluRs originates within individual LBDs with agonist binding inducing closure of the clamshell, separation of the transmembrane domain linkers, and opening of the ion channel gate. Desensitization (inactivation) results from rupture of the agonist-bound LBD dimer D1-D1 interface, leading to rigid-body rotation of individual LBD domains within the dimer and allowing for D2 domains, linkers to the ion channel and the ion channel gate to adopt a closed-state-like conformation. Gating can be perturbed at many sites by small molecule inhibitors and modulators, and by auxiliary protein subunits (Supplementary Fig. 34 ). The underlying architecture and symmetry of iGluRs, as revealed by the GluA2 cryst structure, has implications for understanding how these molecules perturb receptor function.
METHODS SUMMARY
The GluA2 cryst -green fluorescent protein (GFP) fusion (see Methods) was expressed in baculovirus-infected Sf9 insect cells and was purified using metalaffinity chromatography in buffers supplemented with 1.0 mM n-dodecyl-b-Dmaltoside. Following cleavage by thrombin to remove GFP, the receptor was further purified by size-exclusion chromatography in a buffer supplemented with 1 mM n-undecyl-b-D-thiomaltoside and synthetic lipids. Crystallization was performed under paraffin oil, at 4 uC, using a precipitating solution composed of 7-11% (w/v) PEG 20,000, 0.1 M 2-(N-morpholino)-ethanesulphonic acid (MES; pH 6.0-6.5) and 300 mM [[3,4-dihydro-7-(4-morpholinyl)-2,3-dioxo -6-(trifluoromethyl)-1(2H)-quinoxalinyl]methyl]phosphonic acid (ZK200775). Selenomethionine-labelled receptor was prepared and crystallized using similar conditions. Diffraction data sets were indexed, integrated and scaled using HKL2000. Initial phase information was obtained by molecular replacement using the isolated N-terminal domains and ligand-binding domains as search probes. The ion channel and interdomain polypeptides were iteratively built using the computer graphics program Coot and the structure was refined using the computer program Phenix. The ion channel functional activity of the GluA2 cryst construct was measured by whole-cell or outside-out patch clamp experiments. Ligand binding activity was evaluated by 3 H-AMPA saturation and competition assays. NMDA receptor crosslinking experiments were done by transiently transfecting human embryonic kidney tsA 201 cells with wild-type or mutant GluN1 and GluN2A plasmid DNA and analysing oligomeric behaviour of protein on gradient SDS-PAGE gels by western blot analysis. Structure superpositions were done using Superpose (CCP4).
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
